BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8017812)

  • 1. Survival in colorectal carcinoma associated with previous extracolonic cancer.
    Varty PP; Delrio P; Boulos PB
    Ann R Coll Surg Engl; 1994 May; 76(3):180-4. PubMed ID: 8017812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
    Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
    Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metachronous colorectal cancer: a competing risks analysis with consideration for a stratified approach to surveillance colonoscopy.
    Battersby NJ; Coupland A; Bouliotis G; Mirza N; Williams JG
    J Surg Oncol; 2014 Apr; 109(5):445-50. PubMed ID: 24272767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
    Bova R; Kamphues C; Neuhaus P; Puhl G
    Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does concurrent splenectomy at colorectal cancer resection influence survival?
    Varty PP; Linehan IP; Boulos PB
    Dis Colon Rectum; 1993 Jun; 36(6):602-6. PubMed ID: 7684667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer.
    Ikeguchi M; Ohfuji S; Oka A; Tsujitani S; Maeda M; Kaibara N
    Hepatogastroenterology; 1995; 42(5):672-6. PubMed ID: 8751233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple colorectal cancers. A population based study].
    Cauvin JM; Boutron MC; Arveux P; Liabeuf A; Grobost O; Faivre J
    Gastroenterol Clin Biol; 1992; 16(1):16-20. PubMed ID: 1537477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple primary malignancies involving colorectal cancer--clinical characteristics and prognosis with reference to surveillance.
    Lee WS; Lee JN; Choi S; Jung M; Baek JH; Lee WK
    Langenbecks Arch Surg; 2010 Apr; 395(4):359-64. PubMed ID: 19763603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young age is not a poor prognostic marker in colorectal cancer.
    Chung YF; Eu KW; Machin D; Ho JM; Nyam DC; Leong AF; Ho YH; Seow-Choen F
    Br J Surg; 1998 Sep; 85(9):1255-9. PubMed ID: 9752871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in patients with metachronous second primary lung cancer.
    Ha D; Choi H; Chevalier C; Zell K; Wang XF; Mazzone PJ
    Ann Am Thorac Soc; 2015 Jan; 12(1):79-84. PubMed ID: 25494009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.